These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 30767667)
1. The Distribution Volume of Roy J; Kuo F; Basuli F; Williams MR; Wong K; Green MV; Seidel J; Adler SS; Xu B; Choyke PL; Jagoda EM Cancer Biother Radiopharm; 2019 May; 34(4):238-244. PubMed ID: 30767667 [No Abstract] [Full Text] [Related]
2. Improved PET imaging of tumors in mice using a novel (18) F-folate conjugate with an albumin-binding entity. Fischer CR; Groehn V; Reber J; Schibli R; Ametamey SM; Müller C Mol Imaging Biol; 2013 Dec; 15(6):649-54. PubMed ID: 23760583 [TBL] [Abstract][Full Text] [Related]
3. Optimization of Early Response Monitoring and Prediction of Cancer Antiangiogenesis Therapy via Noninvasive PET Molecular Imaging Strategies of Multifactorial Bioparameters. Bao X; Wang MW; Luo JM; Wang SY; Zhang YP; Zhang YJ Theranostics; 2016; 6(12):2084-2098. PubMed ID: 27698942 [No Abstract] [Full Text] [Related]
4. MicroPET imaging of tumor angiogenesis and monitoring on antiangiogenic therapy with an (18)F labeled RGD-based probe in SKOV-3 xenograft-bearing mice. Yang G; Nie P; Kong Y; Sun H; Hou G; Han J Tumour Biol; 2015 May; 36(5):3285-91. PubMed ID: 25501513 [TBL] [Abstract][Full Text] [Related]
5. Immuno-PET imaging of tumor endothelial marker 8 (TEM8). Kuo F; Histed S; Xu B; Bhadrasetty V; Szajek LP; Williams MR; Wong K; Wu H; Lane K; Coble V; Vasalatiy O; Griffiths GL; Paik CH; Elbuluk O; Szot C; Chaudhary A; St Croix B; Choyke P; Jagoda EM Mol Pharm; 2014 Nov; 11(11):3996-4006. PubMed ID: 24984190 [TBL] [Abstract][Full Text] [Related]
6. (18)F-alfatide II and (18)F-FDG dual-tracer dynamic PET for parametric, early prediction of tumor response to therapy. Guo J; Guo N; Lang L; Kiesewetter DO; Xie Q; Li Q; Eden HS; Niu G; Chen X J Nucl Med; 2014 Jan; 55(1):154-60. PubMed ID: 24232871 [TBL] [Abstract][Full Text] [Related]
7. Monitoring response to gefitinib in nude mouse tumor xenografts by (18)F-FDG microPET-CT: correlation between (18)F-FDG uptake and pathological response. Zhou LN; Wu N; Liang Y; Gao K; Li XY; Zhang LF World J Surg Oncol; 2015 Mar; 13():111. PubMed ID: 25888731 [TBL] [Abstract][Full Text] [Related]
8. [Correlation of 3'-deoxy-3'-18F-fluorothymidine uptake to cell proliferation in lung carcinoma xenografts]. Liu X; Zhou NK; Zhang JM; Liang ZY; Zheng X Ai Zheng; 2006 Dec; 25(12):1512-6. PubMed ID: 17166377 [TBL] [Abstract][Full Text] [Related]
9. Monitoring Src status after dasatinib treatment in HER2+ breast cancer with McKnight BN; Viola-Villegas NT Breast Cancer Res; 2018 Oct; 20(1):130. PubMed ID: 30359299 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and Bioevaluation of Novel [ Yang X; Wang F; Zhu H; Yang Z; Chu T Mol Pharm; 2019 May; 16(5):2118-2128. PubMed ID: 30964298 [TBL] [Abstract][Full Text] [Related]
11. 18F-FAZA PET imaging response tracks the reoxygenation of tumors in mice upon treatment with the mitochondrial complex I inhibitor BAY 87-2243. Chang E; Liu H; Unterschemmann K; Ellinghaus P; Liu S; Gekeler V; Cheng Z; Berndorff D; Gambhir SS Clin Cancer Res; 2015 Jan; 21(2):335-46. PubMed ID: 25381339 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of 64Cu labeled GX1: a phage display peptide probe for PET imaging of tumor vasculature. Chen K; Sun X; Niu G; Ma Y; Yap LP; Hui X; Wu K; Fan D; Conti PS; Chen X Mol Imaging Biol; 2012 Feb; 14(1):96-105. PubMed ID: 21360213 [TBL] [Abstract][Full Text] [Related]
13. Stratification of 18F-labeled PET imaging agents for the assessment of antiangiogenic therapy responses in tumors. Goggi JL; Bejot R; Moonshi SS; Bhakoo KK J Nucl Med; 2013 Sep; 54(9):1630-6. PubMed ID: 23907757 [TBL] [Abstract][Full Text] [Related]
14. Zr-89 Immuno-PET Targeting Ectopic ATP Synthase Enables In-Vivo Imaging of Tumor Angiogenesis. Park BN; Kim GH; Ko SA; Shin GH; Lee SJ; An YS; Yoon JK Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31412537 [TBL] [Abstract][Full Text] [Related]
16. Concurrent imaging of vascularization and metabolism in a mouse model of paraganglioma under anti-angiogenic treatment. Facchin C; Perez-Liva M; Garofalakis A; Viel T; Certain A; Balvay D; Yoganathan T; Woszczyk J; De Sousa K; Sourdon J; Provost J; Tanter M; Lussey-Lepoutre C; Favier J; Tavitian B Theranostics; 2020; 10(8):3518-3532. PubMed ID: 32206105 [No Abstract] [Full Text] [Related]
17. The feasibility of 18F-AlF-NOTA-PRGD2 PET/CT for monitoring early response of Endostar antiangiogenic therapy in human nasopharyngeal carcinoma xenograft model compared with 18F-FDG. Cui Y; Liu H; Liang S; Zhang C; Cheng W; Hai W; Yin B; Wang D Oncotarget; 2016 May; 7(19):27243-54. PubMed ID: 27029065 [TBL] [Abstract][Full Text] [Related]
18. PET Imaging of Liu F; Xu X; Zhu H; Zhang Y; Yang J; Zhang L; Li N; Zhu L; Kung HF; Yang Z Mol Pharm; 2018 Aug; 15(8):3448-3455. PubMed ID: 29985631 [TBL] [Abstract][Full Text] [Related]
19. Enhancing Treatment Efficacy of Kuo HT; Merkens H; Zhang Z; Uribe CF; Lau J; Zhang C; Colpo N; Lin KS; Bénard F Mol Pharm; 2018 Nov; 15(11):5183-5191. PubMed ID: 30251544 [TBL] [Abstract][Full Text] [Related]
20. Early monitoring antiangiogenesis treatment response of Sunitinib in U87MG Tumor Xenograft by (18)F-FLT MicroPET/CT imaging. Bao X; Wang MW; Zhang YP; Zhang YJ Biomed Res Int; 2014; 2014():218578. PubMed ID: 24860813 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]